Silent reflux is the everyday name for reflux that people blame for throat and voice symptoms, such as constant throat clearing, hoarseness, a nagging cough, or extra mucus, often with little or no heartburn. Many people who come to us with these symptoms have already been told they have silent reflux and have been on acid medicine for months without much change. Current guidance from gastroenterology and ear, nose, and throat specialists explains why: throat symptoms are common, reflux is only one of several possible causes, and the label is often applied before anyone has checked. This page walks through what the newest consensus says, for adults in Arlington, Annandale, and the rest of Northern Virginia who want to understand where reflux testing fits.
This article is general education, not medical advice. If you have ongoing throat or voice symptoms, talk with a clinician who knows your history before you start, stop, or change any medication.
What silent reflux means
Doctors have long used the term laryngopharyngeal reflux, or LPR, for the idea that stomach contents travel up past the esophagus and irritate the throat (the pharynx) and voice box (the larynx). "Silent" refers to the fact that the usual reflux symptoms in the chest, heartburn and regurgitation, may be mild or absent.
The trouble with the term is that it has been used for almost any throat complaint, with or without proof that reflux is involved. In 2026, a 28-member international group of experts in gastroenterology, ear, nose, and throat surgery, speech-language pathology, and psychology published the San Diego Consensus for Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease in the American Journal of Gastroenterology. It separates two ideas that the old label blurred together:
- Laryngopharyngeal symptoms (LPS): recurrent throat or upper airway symptoms that occur at least twice a week for more than eight weeks, and that may or may not come from reflux.
- Laryngopharyngeal reflux disease (LPRD): those symptoms plus objective evidence of reflux.
The consensus is plain about the gap between the two. Having the symptoms does not mean having the disease, and it estimates that only about 35% of people evaluated for these symptoms are found to have objective reflux disease. In other words, many people told they have silent reflux turn out, on testing, not to have it.
Symptoms often blamed on silent reflux
The San Diego panel agreed that these symptoms count as laryngopharyngeal symptoms:
- Cough
- Regurgitation
- Throat pain or a sore throat
- Frequent throat clearing
- Excess phlegm
- Hoarseness or a change in your voice
Several other complaints often linked to silent reflux did not reach agreement, including a burning tongue, post-nasal drip, bad breath, belching, and trouble swallowing. Globus, the feeling of a lump in the throat, came close. The panel said it deserves evaluation but is often a sign that reflux is not the cause.
A companion review published in Neurogastroenterology and Motility in May 2026, Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease: Diagnostic Testing and Clinical Approach, adds a useful distinction. Episodic symptoms such as cough, throat clearing, and regurgitation may be tied to reflux episodes more often than continuous ones such as throat pain, phlegm, and voice changes.
None of these symptoms, on its own, proves reflux. The American College of Gastroenterology's 2022 clinical guideline for the diagnosis and management of GERD notes that chronic cough, hoarseness, asthma, sinusitis, laryngitis, and dental erosions have all been associated with reflux, but that they are poor at identifying it. Diagnosing reflux from these symptoms alone, or from whether they improve on a proton pump inhibitor (PPI), is unreliable and not recommended.
Why silent reflux is often the wrong label
The ACG's first recommendation on symptoms outside the esophagus is a strong one: look for causes other than reflux before attributing them to reflux. Depending on the symptoms, the guideline says, evaluation by ear, nose, and throat, allergy, or lung specialists should be considered.
The guidelines name a range of things that can produce the same complaints:
- Allergy, smoking, and environmental irritants, which can inflame the throat and voice box.
- Infections of the throat or airway.
- Problems of the vocal cords themselves, including benign growths, strain from heavy voice use, and, less often, precancerous or cancerous lesions. These can cause hoarseness, throat clearing, and a lump sensation.
- Esophageal motility disorders such as achalasia, which can mimic reflux.
- Behavioral patterns such as supragastric belching and rumination. Our page on excessive belching explains these.
- An oversensitive larynx. The consensus describes a cycle of laryngeal hypersensitivity, an exaggerated response to small triggers, and hypervigilance, in which a throat that has been irritated keeps reacting and keeps drawing attention. It is careful to say this does not mean a mental health disorder.
The consensus links these other mechanisms to a figure worth knowing: fewer than half of people with laryngopharyngeal symptoms respond to acid-suppressing treatment alone. Chronic cough is a good example. The 2026 review cites a multicenter trial in which reflux was the main driver in only about a quarter of people with chronic unexplained cough.
What a throat exam can and cannot show
Many people first hear the words silent reflux after a laryngoscopy, a look at the voice box with a small scope, usually done by an ear, nose, and throat specialist. Redness or swelling in the back of the larynx has traditionally been read as a sign of reflux.
Both the ACG and the San Diego Consensus say that is not enough. The ACG suggests against diagnosing laryngopharyngeal reflux from laryngoscopy findings alone. The San Diego panel agreed the findings are not specific to reflux and can appear in healthy people or with other kinds of inflammation. It also advised that scoring tools built on those findings should not be used to diagnose reflux disease.
Laryngoscopy still matters. The consensus calls it a necessary part of the evaluation, because it is how other causes, including growths and cancer, are found. When it does not explain hoarseness, the panel recommends videostroboscopy, a slow-motion look at how the vocal cords vibrate. Those exams belong to ear, nose, and throat care. Gastroenterology comes in when the question becomes whether reflux from the stomach is actually present.
Silent reflux with heartburn and without it
The most important question in the current approach is a simple one: along with the throat symptoms, do you also have heartburn or regurgitation? The answer changes the next step.
Throat symptoms plus heartburn or regurgitation
When typical reflux symptoms are present too, reflux is more likely to be involved. For this group, the ACG suggests considering a trial of twice-daily PPI therapy for 8 to 12 weeks before further testing. The San Diego Consensus describes a similar trial, a standard-dose PPI twice a day for about three months, with or without an alginate (a medicine that forms a barrier on top of stomach contents), along with diet and lifestyle changes. The 2026 review notes that this approach is reasonable when there are no warning signs such as weight loss, painful swallowing, coughing up blood, or swallowing that is getting worse.
The consensus lists lifestyle steps that reduce reflux: managing weight, avoiding tight clothing around the waist, staying upright for two to three hours after meals, raising the head of the bed or sleeping on the left side when reflux happens at night, and avoiding foods that trigger symptoms. Our acid reflux and GERD page covers these in more detail.
If the trial does not help, the next step is testing, not an ever-higher dose.
Throat symptoms without heartburn
When there is no heartburn or regurgitation, the guidelines point the other way. The ACG makes a strong recommendation that people with these symptoms and no typical reflux symptoms have reflux testing before PPI therapy. The San Diego Consensus agrees: for isolated throat symptoms, acid-reducing medicines are not recommended as first-line therapy until there is objective evidence of reflux.
That can feel backward, since a pill seems simpler than a test. The 2026 review gives the reasoning. People with throat symptoms alone have a lower chance of reflux and respond much less often to acid suppression, so empiric treatment tends to mean months of medication that may not be needed. It cites a study in which testing up front cost less on average than starting with twice-daily medicine.
How silent reflux is tested
When testing is needed, two kinds of study do most of the work. Both are described in the San Diego Consensus and the 2026 review.
Upper endoscopy
An upper endoscopy (EGD) lets a gastroenterologist look at the lining of the esophagus, stomach, and first part of the small intestine. The consensus recommends starting esophageal testing with an endoscopy, performed off acid-suppressing medicine when possible so that any damage is easier to see. Certain findings are conclusive evidence of reflux disease: more severe inflammation of the esophagus (erosive esophagitis graded above LA grade B), Barrett's esophagus confirmed on biopsy, or a narrowing from reflux called a peptic stricture. An endoscopy can also show a hiatal hernia, which supports the diagnosis, and other conditions such as eosinophilic esophagitis.
The limitation is that most people with throat symptoms have a normal endoscopy. In a multicenter study of 756 people cited in the 2026 review, 7.4% had the more severe grades of inflammation and 3.3% had Barrett's esophagus. The ACG makes the same point: endoscopy should not be the method used to establish reflux as the cause of cough, asthma, or throat symptoms, and finding esophagitis proves reflux is present without proving it is what irritates the throat.
Ambulatory reflux monitoring
Reflux monitoring measures how much reflux actually happens over a day or more. The 2026 review calls it the reference test for measuring reflux in people being evaluated for throat symptoms. There are two main types:
- Catheter-based pH-impedance monitoring. A thin tube passes through the nose into the esophagus and stays in place for 24 hours. It detects acid and non-acid reflux, liquid and gas, and how high each episode travels. The review recommends it for throat symptoms without heartburn. Some versions add sensors in the throat itself, though experts have not agreed on normal values for those readings.
- Wireless pH monitoring. A small capsule is attached to the lower esophagus during an endoscopy and records acid for 48 to 96 hours, with no tube. It is better tolerated and captures day-to-day variation, but it measures only acid and only in the lower esophagus. The review sees it as better suited to people who also have heartburn or regurgitation, or to anyone who cannot tolerate the catheter. The ACG adds that a normal result over 96 hours is evidence against acid reflux as the cause.
Where the testing is done depends on the test and the facility. If testing is part of your evaluation, your gastroenterologist can explain which study fits your situation and where it is performed.
Testing on or off medicine
Whether to stop acid medicine before reflux monitoring depends on the question being asked. The 2026 review explains that when reflux has not been proven, testing is done off acid-reducing medicine, because a negative result on medication only shows that the medicine is working. It cites stopping PPIs for at least seven days and H2 blockers for at least 48 hours before an off-medication test, while weighing rebound symptoms. When reflux is already proven and symptoms continue despite treatment, testing is done on medication to sort out why. Do not stop a prescribed medication before a test unless the clinician ordering it tells you to.
Tests the guidelines do not recommend
The ACG recommends against salivary pepsin testing for these symptoms, because it does not reliably separate people with throat symptoms from people without them. It also does not routinely recommend oropharyngeal pH monitoring, a sensor placed at the back of the throat. The 2026 review advises against pH-only catheter testing for throat symptoms. Esophageal manometry, which measures how the esophagus squeezes, does not diagnose reflux, but it can rule out motility disorders that mimic it. Our page on difficulty swallowing explains manometry further.
When testing does not show silent reflux
A normal reflux study is useful information, not a dead end. The 2026 review states that when testing shows normal acid exposure and no abnormal reflux reaching higher up, reflux is effectively ruled out as the main cause, and continued reflux treatment is unlikely to help and should be stopped. It describes a negative result as a pivot point toward care aimed at the real mechanism. The San Diego Consensus agrees that symptoms should no longer be considered reflux-related after negative testing.
The ACG guideline shows why that matters. It describes a study in which people whose throat symptoms persisted despite well-controlled acid exposure were offered anti-reflux surgery. At one year, 10% of those who had surgery and 7% of those who stayed on reflux medicine had better throat symptoms, while about two-thirds of those who pursued treatments not aimed at reflux had improved.
What those other treatments look like depends on the cause. The consensus describes laryngeal behavioral therapy delivered by trained speech-language pathologists, cognitive behavioral approaches, and, in some cases, medications that calm an oversensitive nerve response. It also notes that someone can have true reflux disease and an oversensitive larynx at the same time, which is one reason symptoms sometimes persist even when reflux is well treated.
Surgery and procedures for silent reflux
Both documents set a firm rule here. The ACG recommends surgical or endoscopic anti-reflux procedures for these symptoms only in people with objective evidence of reflux. The San Diego panel strongly agreed that evidence linking the symptoms to reflux is needed before any invasive anti-reflux treatment, which it describes as invasive, irreversible, and expensive. The ACG also notes that results of surgery for throat and lung symptoms are worse than for heartburn and regurgitation, with reported improvement ranging from 15% to 95% across small studies.
Long-term acid medicine and silent reflux
Many people with throat symptoms end up on a PPI indefinitely without a confirmed diagnosis. The San Diego Consensus recommends objective evaluation for reflux disease whenever long-term medical anti-reflux treatment is being considered. Our page on long-term PPI use explains how the AGA approaches decisions about continuing or tapering these medicines, and our page on GERD that is not responding to medication covers the step-by-step workup when heartburn persists. If you also have chest discomfort, our noncardiac chest pain page explains how reflux is evaluated once the heart has been checked.
Preparing for a visit about silent reflux
A few details make the first appointment more productive. Before you come in, try to write down:
- Which throat or voice symptoms you have, how often, and for how long. The consensus definition uses at least twice a week for more than eight weeks.
- Whether you also have heartburn, regurgitation, chest discomfort, or trouble swallowing.
- Every reflux medicine you have taken, including over-the-counter PPIs, H2 blockers, antacids, and alginates, how long you took each, and whether anything helped.
- Results from any ear, nose, and throat, allergy, or lung evaluations, including laryngoscopy reports.
- Smoking or vaping history, heavy voice use at work, and known allergies.
Our page on your first gastroenterologist visit covers what else to bring.
Symptoms that should not wait
Some throat and swallowing symptoms need prompt evaluation. The guidelines list warning signs including unintentional weight loss, pain when swallowing, coughing up blood, and swallowing difficulty that is getting worse. Hoarseness that does not go away also deserves an exam of the voice box, since that is how growths and other non-reflux causes are found. Trouble breathing, choking on food that will not pass, or vomiting blood is an emergency: call 911 or go to an emergency department.
Reflux care in Northern Virginia with GC of NoVA
Gastroenterology Center of Northern Virginia cares for adults across Arlington, Annandale, and the surrounding communities. When throat symptoms may be connected to reflux, our five gastroenterologists review your history, look at what has already been tried, and talk through whether an endoscopy or reflux testing would answer the question, using current ACG guidance and the San Diego Consensus. We work alongside the ear, nose, and throat specialists, allergists, and lung doctors who often share these patients. Our page on when to see a gastroenterologist can help you decide whether it is time.
We see patients at our Arlington office at 1715 N George Mason Drive, adjacent to VHC Health, and our Annandale office at 3299 Woodburn Road in the Woodburn Medical complex. To schedule a visit, call Arlington at (703) 522-7476 or Annandale at (703) 560-6106, or learn more at gcofnova.com.
Frequently asked questions about silent reflux
What is silent reflux?
Silent reflux is the common name for laryngopharyngeal reflux, the idea that stomach contents reach the throat and voice box and cause symptoms such as throat clearing, hoarseness, or cough, often without much heartburn. The 2026 San Diego Consensus separates the symptoms from the disease: reflux disease requires objective evidence of reflux, and only about 35% of people evaluated for these symptoms have it.
Can a doctor diagnose silent reflux by looking at my throat?
Not on its own. The American College of Gastroenterology suggests against diagnosing laryngopharyngeal reflux from laryngoscopy findings alone, because redness and swelling of the voice box are not specific to reflux and can appear in healthy people. Laryngoscopy is still important for finding other causes of throat symptoms, including growths.
Should I take a PPI for silent reflux?
It depends on whether you also have heartburn or regurgitation. With those symptoms, the ACG suggests considering a twice-daily PPI trial for 8 to 12 weeks. Without them, the ACG recommends reflux testing before PPI therapy, and the San Diego Consensus does not recommend acid-reducing medicine first. Talk with your clinician before starting or stopping any medication.
What test shows silent reflux?
Ambulatory reflux monitoring is the reference test. Catheter-based pH-impedance monitoring over 24 hours detects acid and non-acid reflux and how high it travels, and is recommended for throat symptoms without heartburn. Wireless pH monitoring records acid for 48 to 96 hours. An upper endoscopy can show conclusive signs of reflux disease, but most people with throat symptoms have a normal one.
What if my reflux test is normal but my throat symptoms continue?
A normal study makes reflux unlikely as the main cause, and the 2026 consensus review says continued reflux treatment is unlikely to help. Other causes then come into focus, including allergy, vocal cord problems, and an oversensitive larynx, which may respond to voice and breathing therapy with a speech-language pathologist or other treatments a clinician recommends.
Is surgery an option for silent reflux?
Only when reflux has been objectively proven. The ACG recommends surgical or endoscopic anti-reflux procedures for throat and airway symptoms only in people with objective evidence of reflux, and notes that results are worse than for heartburn and regurgitation. The San Diego Consensus also requires that evidence before any invasive anti-reflux treatment.
This article is for general education and is not medical advice. Talk with a qualified gastroenterologist about your symptoms, diagnosis, and treatment options.